Quick Takeaways
- Prosight Management, LP filed SCHEDULE 13G for Janux Therapeutics, Inc. Common Stock, $0.001 par value per share (JANX).
- Disclosed ownership: 5.3%.
- Date of event: 03 Feb 2026.
Prosight Management, LP - 03 Feb 2026 SCHEDULE 13G Report for Janux Therapeutics, Inc. Common Stock, $0.001 par value per share (JANX)
- Filing Manager
- Prosight Management, LP
- Reporting Manager
- W. Lawrence Hawkins
- Symbol
- JANX
- Shares outstanding
- 59,570,189 shares
- Disclosed Ownership
- 3,157,220 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Feb 2026, 16:23:27 UTC
- Date of event
- 03 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Prosight Management, LP disclosed 5.3% ownership in Janux Therapeutics, Inc. Common Stock, $0.001 par value per share (JANX) on 03 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Feb 2026, 16:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Prosight Management, LP | 5.2% | 3,150,970 | 0 | 3,150,970 | Prosight Partners, LLC | General Partner | |
| Prosight Fund, LP | 0.2% | 148,416 | 0 | 148,416 | Prosight Management, LP | General Partner | |
| Prosight Plus Fund, LP | 1.1% | 685,220 | 0 | 685,220 | Prosight Management, LP | General Partner | |
| Prosight Partners, LLC | 5.2% | 3,150,970 | 0 | 3,150,970 | /s/ W. Lawrence Hawkins | Sole Manager | |
| W. Lawrence Hawkins | 5.3% | 3,157,220 | 6,250 | 3,150,970 | /s/ W. Lawrence Hawkins | W. Lawrence Hawkins |